Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Precision Biologics, Inc. reports that novel findings from its ongoing phase 2 clinical trial, combining NEO-201 with pembrolizumab for the treatment of patients resistant to prior checkpoint...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, will participate in a fireside chat on June 11, 2024, at the Deutsche Bank Global Auto Industry...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Results will be reviewed during an Oral Presentation on Monday June 3rd Study outcomes demonstrate potential for Adela's MRD test to inform adjuvant treatment decisions and predict and monitor for...
-
May 30, 2024Dive into AI's Transformative Role in Education with Professor Hod Lipson at Anthology Together 2024Virtual Press Office and PR Newswire: General Trade show news
Anthology, the leading provider of education solutions that support the entire learner lifecycle, today announced Professor Hod Lipson of Columbia University, an eminent voice in the fields of...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
4D Path ("the Company"), a company dedicated to personalizing cancer care through their advanced approach to predicting tumor response, is pleased to announce today new clinical data highlighted...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
In this free webinar, learn about the critical role of imaging biomarkers in characterizing patient eligibility, safety and therapeutic efficacy in Alzheimer's disease (AD) clinical trials....
-
May 30, 2024Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual MeetingVirtual Press Office and PR Newswire: General Trade show news
Presentations Cover Aspen's Autologous iPSC-derived Approach for Neuron Replacement Therapy in Trial for Parkinson's Disease SAN DIEGO and VANCOUVER, BC, May 30, 2024 /PRNewswire/ -- Aspen...